We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kings Arms Yard Vct Plc | LSE:KAY | London | Ordinary Share | GB0007174294 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.40 | 18.90 | 19.90 | 19.40 | 19.40 | 19.40 | 12,820 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 3.32M | 726k | 0.0014 | 138.57 | 100.91M |
TIDMKAY Kings Arms Yard VCT PLC Interim Management Statement LEI Code 213800DK8H27QY3J5R45 Introduction I am pleased to present Kings Arms Yard VCT PLC's (the "Company") interim management statement for the period from 1 July 2020 to 30 September 2020. Performance and dividends The Company's unaudited net asset value (NAV) as at 30 September 2020 was GBP77.58 million or 20.71 pence per share (excluding treasury shares), an increase of 0.41 pence per share (2.0 per cent.) since 30 June 2020. After accounting for the dividend paid of 0.51 pence per share on 30 October 2020 to shareholders on the register on 2 October 2020, the NAV is 20.20 pence per share. Share buy-backs During the period from 1 July 2020 to 30 September 2020, the Company purchased 1,705,566 shares for GBP331,000 at an average price of 19.29 pence per share. All of the shares are to be held in treasury. It remains the Board's policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company's interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. The level of share buybacks for the sixth month period to 31 December 2020 will be limited to GBP1 million. It is the Board's intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit. Portfolio The following investments have been made during the period from 1 July 2020 to 30 September 2020: New investments GBP'000 Activity ------------- ------- ------------------------------------------------------- The Voucher Market A cloud platform that enables corporates to purchase Limited (T/A digital gift cards and to distribute them to employees WeGift) 361 and customers. ------------- ------- ------------------------------------------------------- Total new investments 361 ------------- ------- Follow on investments GBP'000 Activity ---------------- ------- --------------------------------------------------- Network analytics platform to detect financial Quantexa Limited 891 crime. ---------------- ------- --------------------------------------------------- AI platform that generates optimised marketing Phrasee Limited 274 campaigns. ---------------- ------- --------------------------------------------------- A patient engagement and data capture platform for uMotif Limited 175 use in real world and observational research. ---------------- ------- --------------------------------------------------- ePatient Network Limited (T/A Online community connecting people affected by rare Raremark) 46 diseases. ---------------- ------- --------------------------------------------------- The Evewell (Harley Street) Operator of a women's health centre focusing on Limited 29 fertility. ---------------- ------- --------------------------------------------------- Total follow on investments 1,415 ---------------- ------- Disposals During the period from 1 July 2020 to 30 September 2020 contracts were exchanged for the sale of Perpetuum Limited, subject to regulatory approval. Top ten holdings as at 30 September 2020: Portfolio Carrying value % of Activity company GBP'000 net asset value ------------ -------------- ----- ------------------------------------------------------- Proveca 7,412 9.6 Reformulation of medicines for paediatric use. Limited ------------ -------------- ----- ------------------------------------------------------- Active Lives 6,986 9.0 Owner and operator of a 75 bed care home in Cumnor Care Hill, Oxfordshire. Limited ------------ -------------- ----- ------------------------------------------------------- Ryefield 4,900 6.3 Owner and operator of a 60 bed care home in Hillingdon, Court Care Middlesex. Limited ------------ -------------- ----- ------------------------------------------------------- Egress 4,545 5.9 Encrypted email & file transfer service provider. Software Technologies Limited ------------ -------------- ----- ------------------------------------------------------- Quantexa 4,300 5.5 Network analytics platform to detect financial crime. Limited ------------ -------------- ----- ------------------------------------------------------- Chonais 3,272 4.2 Owner and operator of a 2 MW hydro-power scheme in River Hydro the Scottish Highlands. Limited ------------ -------------- ----- ------------------------------------------------------- Antenova 2,350 3.0 Supplier of integrated antennas and RF solutions. Limited ------------ -------------- ----- ------------------------------------------------------- The Street 1,914 2.5 Owner and operator of photovoltaic systems on domestic by Street properties in the UK. Solar Programme Limited ------------ -------------- ----- ------------------------------------------------------- Regenerco 1,674 2.2 Generator of renewable energy from roof top solar Renewable installations. Energy Limited ------------ -------------- ----- ------------------------------------------------------- Alto 1,458 1.9 Owner and operator of community scale wind energy Prodotto projects on brownfield sites in the UK. Wind Limited ------------ -------------- ----- ------------------------------------------------------- A full breakdown of the Company's portfolio can be found on the Company's webpage on the Manager's website at https://www.globenewswire.com/Tracker?data=exCee2chLy17nX4itGG3CLPKQ0M3KtNrBlOql4dgcTUWVqcrJ3izUKvrc6l1EN15Mon1ZLPNVRyV-dgYbXx2R1P_GyuCko786Fl-1HlCWN4dumSn8U0g1u1EV8IEk2_o www.albion.capital/funds/KAY, by following the 'Portfolio of Investments' link under the 'Fund reports' section. Material events and transactions after the period end After the period end, the Company undertook the following investment transactions: -- Proceeds of GBP419,000 received from the sale of Clear Review Limited on a cost of GBP203,000; -- Investment of GBP418,000 in a new portfolio company, Seldon Technologies Limited, a software company that enables enterprises to deploy Machine Learning models in production; -- Investment of GBP152,000 in a new portfolio company, uMedeor Limited (T/A uMed), a middleware technology platform that enables life science organisations to conduct medical research programmes; -- Investment of GBP123,000 in an existing portfolio company, Limitless Technology Limited, a provider of a customer service platform powered by the crowd and machine learning technology; and -- Investment of GBP84,000 in an existing portfolio company, Arecor Limited, which develops biopharmaceuticals through the application of a formulation technology platform. There have been no further significant events or transactions that the Board is aware of which would have a material impact on the financial position of the Company between 1 October 2020 and 10 November 2020. Further information The Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this scheme can be found at https://www.globenewswire.com/Tracker?data=exCee2chLy17nX4itGG3CLPKQ0M3KtNrBlOql4dgcTXvl0qqQ0lPzcDkgV4WGmYA-nP_twhogeFR3JpP4wKfSu-6hYXRzNk6l9X7QkipLECb4yU04OZYWJm8B10apJZt www.albion.capital/funds/KAY. Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company's webpage on the Manager's website under https://www.globenewswire.com/Tracker?data=exCee2chLy17nX4itGG3CLPKQ0M3KtNrBlOql4dgcTU-V6FF6Jo9cE0XGIKcMiKouw1LSfxSdQX9iSEVoJkxSNDCOG6PJzNuODxC9Do_FS7-RSI8buXosroS5PfElxBr www.albion.capital/funds/KAY. Robin Field, Chairman 10 November 2020 For further information please contact: Albion Capital Group LLP -- Tel: 020 7601 1850
(END) Dow Jones Newswires
November 10, 2020 11:05 ET (16:05 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Kings Arms Yard Vct Chart |
1 Month Kings Arms Yard Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions